Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis

Clinical trial NCT06519591 · RECRUITING

Trial details

NCT number

NCT06519591

Sponsor

Ruijin Hospital

Status

RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2025-02-25

Primary completion

2027-01-01

Enrollment

40

View on ClinicalTrials.gov